- 영문명
- Risk Factors and Prognosis of Recurrent Thyroid Cancer
- 발행기관
- 대한내분비외과학회
- 저자명
- 이준혁 정진향 황규하 박호용 이영하 Jun-Hyuk Lee M.D. Jin-Hyang Jung M.D. Gyu-Ha Hwang M.D. Ho-Yong Park M.D. and Young-Ha Lee M.D.
- 간행물 정보
- 『The Koreran journal of Endocrine Surgery』4권2호, 90~96쪽, 전체 7쪽
- 주제분류
- 의약학 > 면역학
- 파일형태
- 발행일자
- 2004.12.30
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

국문 초록
영문 초록
Purpose: Differentiated thyroid cancer is known to be one of cancers which have a favorable prognosis and long-term survival resulting from slow growth of tumor and late distant metastasis. Patients are nearly cured of thyroid cancer after first operation. But, some of those have high risk factors of recurrence. Practically it has been reported that 20% of those have recurrence of cancer and 50∼60% of patients died of recurrence. We analyzed factors involving to recurrence after initial treatment, frequency and site of recurrence, disease-free interval, and results of treatment. Based on this information, we investigated therapeutics to decrease the rate of recurrence and prognostic factors to expect death. Methods: 1803 patients were primarily operated for thyroid cancer in Kyungpook National University Hospital between 1985 and 2003. Among the cases, we reviewed the clinical records of 124 patients (6.9%) who had recurrent thyroid cancer. We analyzed the difference in frequency of recurrence on the basis of sex, age, histologic types, risk groups, and lymph node metastases when they had a first operation. The correlation between these factors and mortality rate was analyzed statistically by using Chi-square test and Fisher's exact probability test. Results: Post-operative recurrence of thyroid cancer was highly observed in over 40 years old at first operation (8.4% vs. 4.9%), men (17.1% vs. 3.9%). Similarly, in the case of medullary or poorly-differentiated thyroid cancers, the groups of patients with high-risk (12.3% vs. 3.9%) or with lymph node metastases (13.5% vs. 3.7%) have high frequency of recurrence. Among the 124 patients, 53.3% cases haveregional recurrence sites and 20.1% have local, 17.7% distant metastases, and 1.6% combined locoregional. The number of patients who died of recurrent cancer was 32 of 124 cases. Major cause of the death was distant metastases. In the case of 104 patients who had recurrent differentiated thyroid cancer, significant prognostic indicators of low survival rates are age greater than 45 years, neck dissection at second operation and distant metastases. Conclusion: In order to decrease the rate of local and regional recurrence in thyroid cancer, we conclude that complete resections of thyroid tissue and cervical lymph nodes have to be operated specially in the group with high-risk. Although adjacent organs are infiltrated, active treatment should be carried out. The treatment of most medullary or poorly-differentiated thyroid cancers which result in the death of distant metastases still remains to be studied. (Korean J Endocrine Surg 2004;4:90-96)
목차
해당간행물 수록 논문
- 일차성 부갑상선 기능항진증 수술 후 일시적 혹은 반복적으로 부갑상선 호르몬 증가가 있던 환자의 추적관찰 결과
- 아급성 갑상선염
- 갑상선 일엽절제시 수술방법에 따른 임상적 비교 고찰
- 유두상 갑상선암의 원주형 변이 2예
- 윌슨병 환자에서 다발성 섬유선종을 동반한 거대유방증 1예
- 재발 갑상선암의 위험 인자 및 예후
- 기관식도 침범이 있는 분화 갑상선암의 치료
- 부갑상선 낭종의 진단적 접근 및 치료
- 갑상선 수질암에서 예방적 측경부 림프절절제술의 범위
- 갑상선 종양에서 Heat Shock Protein70과 Heat Shock Protein90의 발현 양상
- 갑상선 편측형성부전
- 측경부 낭종으로 발현된 유두상 갑상선암
- 갑상선 종괴로 의심되었던 전종격동 성숙 낭성 기형종
참고문헌
관련논문
의약학 > 면역학분야 BEST
- 간호대학생의 SNS 중독경향성, 간호정보역량, 정보윤리 의식이 환자 개인정보 보호 인식에 미치는 영향
- 혼종모형을 이용한 요양병원 간호사의 치료적 말벗간호에 대한 개념분석
- 간호·보건계열 대학생을 위한 시뮬레이션 기반 환자안전 교육프로그램의 효과
의약학 > 면역학분야 NEW
- Parents’ employment and non-chromosomal congenital anomalies in Korea: a national population cohort study
- Impact of hypertension-related avoidable hospitalization on all-cause mortality in older patients with hypertension: a nationwide retrospective cohort study in Korea
- Association between regular dental scaling and stroke risk in patients with periodontal diseases: evidence from a Korean nationwide database
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!
